BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4934424)

  • 21. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COMPARISON OF TUMOUR ANTIGENS IN AKR AND GROSS VIRUS (PASSAGE A)-INDUCED LEUKAEMIAS.
    WAHREN B
    Nature; 1965 Jan; 205():409-10. PubMed ID: 14243441
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of a rapidly growing AKR lymphoblastic cell line maintaining Gross antigens and viral replication.
    Woods WA; Wivel NA; Massicot JG; Chirigos MA
    Cancer Res; 1970 Aug; 30(8):2147-55. PubMed ID: 4918189
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of pyran copolymer on oncogenic virus infections in immunosuppressed hosts.
    Hirsch MS; Black PH; Wood ML; Monaco AP
    J Immunol; 1972 May; 108(5):1312-8. PubMed ID: 4337673
    [No Abstract]   [Full Text] [Related]  

  • 25. [New data on hydrosoluble graft antigens from BP-8 tumoral murine cells].
    Halle-Pannenko O; Kiger N; Martyré MC; Jolles P
    Rev Fr Etud Clin Biol; 1969 Mar; 14(3):288-91. PubMed ID: 4892732
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune response to Gross virus-induced lymphoma. I. Kinetics of cytotoxic antibody response.
    Herberman RB; Oren ME
    J Natl Cancer Inst; 1971 Feb; 46(2):391-6. PubMed ID: 5115906
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-induced skin heterogenization. 3. Immunologic and immunogenetic mechanisms.
    Liozner AL; Svet-Moldavsky GJ; Mkheidze DM
    J Natl Cancer Inst; 1970 Sep; 45(3):485-94. PubMed ID: 4943065
    [No Abstract]   [Full Text] [Related]  

  • 29. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR
    J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract]   [Full Text] [Related]  

  • 30. Immune response to Gross virus-induced lymphoma. II. Kinetics of the cellular immune response.
    Oren ME; Herberman RB; Canty TG
    J Natl Cancer Inst; 1971 Mar; 46(3):621-8. PubMed ID: 5547316
    [No Abstract]   [Full Text] [Related]  

  • 31. Skin as a vehicle for horizontal transmission of gross passage a leukemia in adult mice. A unique microenvironment?
    Mariani T
    Adv Exp Med Biol; 1976; 66():699-704. PubMed ID: 773130
    [No Abstract]   [Full Text] [Related]  

  • 32. Rejection of skin allografts by irradiation chimeras: evidence for skin-specific transplantation barrier.
    Lance EM; Boyse EA; Cooper S; Carswell EA
    Transplant Proc; 1971 Mar; 3(1):864-8. PubMed ID: 4937982
    [No Abstract]   [Full Text] [Related]  

  • 33. Survival of mouse skin isografts from leukemic donors.
    Meeker WR; Mirand EA; Grace JT
    J Surg Oncol; 1969; 1(1):19-22. PubMed ID: 4939633
    [No Abstract]   [Full Text] [Related]  

  • 34. Wild-type Gross leukemia virus. 3. Serological tests as indicators of leukemia risk.
    Aoki T; Boyse EA; Old LJ
    J Natl Cancer Inst; 1968 Jul; 41(1):103-10. PubMed ID: 4873848
    [No Abstract]   [Full Text] [Related]  

  • 35. Biologic effects of the altered MHS profile on the K36 tumor, a spontaneous leukemia of AKR.
    Festenstein H; Schmidt W; Testorelli C; Marelli O; Simpson S
    Transplant Proc; 1980 Mar; 12(1):25-8. PubMed ID: 7368290
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of resistance against the transplantation of leukemias induced by Rauscher virus.
    Bianco AR; Glynn JP; Goldin A
    Cancer Res; 1966 Aug; 26(8):1722-8. PubMed ID: 5923170
    [No Abstract]   [Full Text] [Related]  

  • 37. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 38. AKR murine leukemia viruses and long-term bone marrow cultures from AKR and SJL mice.
    Hays EF; Warren J; Hale L; Rodensky D
    Exp Hematol; 1980 Jan; 8(1):134-46. PubMed ID: 6250871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative leukemia: of mice and men.
    Pasqualini CD
    Medicina (B Aires); 1981; 41 Suppl():199-206. PubMed ID: 7345344
    [No Abstract]   [Full Text] [Related]  

  • 40. The antigenic stability of 3 AKR leukemias on isotransplantation and the serologic detection of thymus-derived leukemia cells.
    Reif AE; Allen JM
    Cancer Res; 1966 Jan; 26(1):123-30. PubMed ID: 5901736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.